{"listing":{"listing_type":"company","name":"Keylika","slug":"keylika","tagline":"Redefining the Standard of Care for Iron Deficiency Anemia","description":"Keylika is an early stage biopharma startup developing metal-based drugs using a platform synthesis technology to treat unmet medical needs. We then administer these drugs using proven delivery technologies to effect the best clinical outcomes. \n\nOur first product is a small molecule iron drug (new molecular entity) delivered by a wearable skin patch to treat Iron Deficiency Anemia (IDA), with significantly higher safety, efficacy and tolerability over existing treatments. This is poised to be a best-in-class, potentially breakthrough therapy for treating iron deficiency without any GI side-effects (eg. nausea, constipation, diarrhea, etc.) typically associated with oral iron supplements, and without the risks, costs and side-effects associated with IV iron infusions. When approved, Keylika’s proprietary transdermal iron will be the world's first prescription iron patch. Iron deficiency is a hugely understated problem affecting about 1.6 billion people worldwide and more than 30 million in the US alone, translating to a $17B US market.\n\nKeylika is a Y Combinator company (Summer 2022). YC-listed status: Active.","url":"https://www.keylika.com/","is_stealth":false,"normalized_domain":"keylika.com","normalized_url_key":"keylika.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/bd12fc4dc5d053441f31a9c528579e0d16f3449e.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/keylika","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://www.keylika.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.keylika.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Therapeutics","AI-powered Drug Discovery","Medical Devices","Drug Delivery","Nanotechnology"],"stage":null,"founded_year":null,"location":"San Francisco, CA, USA; Walnut Creek, CA, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T07:00:15.920Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Summer 2022","AI-powered Drug Discovery","Medical Devices","Drug Delivery","Nanotechnology","Therapeutics"],"one_liner_for_search":"Keylika — Redefining the Standard of Care for Iron Deficiency Anemia (Y Combinator Summer 2022)","canonical_facts":["Y Combinator batch: Summer 2022","YC company status: Active","Team size (per YC directory): 1","YC industry: Healthcare","YC subindustry: Healthcare / Therapeutics","Regions (per YC): United States of America, America / Canada, Remote, Partly Remote"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T07:00:15.920Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"ai-powered-drug-discovery","name":"AI-powered Drug Discovery","note":null,"profile_url":"/industries/ai-powered-drug-discovery"},{"kind":"industry","slug":"drug-delivery","name":"Drug Delivery","note":null,"profile_url":"/industries/drug-delivery"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"medical-devices","name":"Medical Devices","note":null,"profile_url":"/industries/medical-devices"},{"kind":"industry","slug":"nanotechnology","name":"Nanotechnology","note":null,"profile_url":"/industries/nanotechnology"},{"kind":"industry","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/industries/therapeutics"}]}}